Erin Olson

Title: The Innovative Contributions of Erin Olson

Introduction

Erin Olson is a notable inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid state forms of specific compounds. Her work is aimed at improving treatment options for various cancers.

Latest Patents

Erin Olson holds 1 patent related to pharmaceutical solid state forms. This invention provides and describes solid state 17α-ethynyl-5α-androstane-3α,17β-diol, including amorphous and crystalline forms, as well as specific polymorphic forms. The patent also covers anhydrates and solvates of the compound, including Form III anhydrate and Form I solvate. Furthermore, the invention relates to solid and suspension formulations containing the compound, which are intended for treating cancers or precancers, such as prostate cancer or breast cancer, in human patients. Additionally, it includes methods for creating liquid formulations from solid state forms of the compound.

Career Highlights

Erin Olson is currently associated with Harbor Therapeutics, Inc., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to advancing medical treatments through her inventions.

Collaborations

Some of her notable coworkers include Steven K White and Keith Lorimer, who contribute to her innovative projects and research efforts.

Conclusion

Erin Olson's contributions to pharmaceutical innovations demonstrate her dedication to improving cancer treatment options through her inventive work. Her patent on solid state forms of specific compounds highlights her role as a significant figure in the field of pharmaceuticals.